ClinicalTrials.Veeva

Menu

Pregabalin Treatment for Trigger Points

F

Fatih Sultan Mehmet Training and Research Hospital

Status

Completed

Conditions

Myofascial Pain Syndrome

Treatments

Drug: Pregabalin 150mg

Study type

Interventional

Funder types

Other

Identifiers

NCT04600037
FSMEAH-KAEK 2014/20

Details and patient eligibility

About

Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study

Full description

We randomized 40 patients into two groups, and 17 patients per group completed the study. Patients in group I received pregabalin and exercise therapy, whereas those in group II received exercise therapy alone. All patients were evaluated as follows: for pain by VAS; trigger-point pressure pain threshold-(PPT) by algometry; neuropathic pain using DN4 and quality of life with the SF36. Evaluations were performed pretreatment and at the end of the first and third months of treatment.

Enrollment

40 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who diagnosed fibromyalgia syndrome,
  • Patients who were also diagnosed as cervical myofascial pain syndrome based on the upper trapezius muscle

Exclusion criteria

  • Patients who had received dry needling or local anesthetic injection to trigger point in the dominant upper trapezius muscle within 3 months of the start of the study.
  • renal insufficiency,
  • impaired liver function,
  • malignancy,
  • pregnancy
  • infections,
  • history of drug or alcohol abuse

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Group 1
Active Comparator group
Description:
Patients received pregabalin (target dose 300 mg/day) and exercise therapy (stretching exercises for the trapezius muscle). Patients were instructed to perform 10 repetitions three times a day., 3 months
Treatment:
Drug: Pregabalin 150mg
Group 2
No Intervention group
Description:
Patients received exercise therapy alone (stretching exercises for the trapezius muscle). Patients were instructed to perform 10 repetitions three times a day., 3 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems